AMLX
AMLX
NASDAQ · Pharmaceuticals

Amylyx Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$32.91
-0.09 (-0.27%)
As of Sep 23, 1:35 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target +12.9% upside
Low Target $28.49
Average Target $37.15
High Target $49.81
Current Price $32.91
Current
$32.91
Target
$37.15
$28.49 $37.15 avg $49.81
Scenario Analysis
Bear Case
$28.49
-13.4%
Low target
Base Case
$37.15
+12.9%
Avg target
Bull Case
$49.81
+51.4%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$41.14
-20.0% from high
52-Week Low
$10.83
+203.9% from low
Target vs 52W High
$37.15
-9.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +15.8%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +11.9%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +7.9%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +20.9%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +192.4%